APA

Bar J., Ding K., Zhao H., Han L., Laurie S. A., Seymour L., Addison C. L., Shepherd F. A., Goss G. D., Dimitroulakos J. & Bradbury P. A. (20160815). Angiotensin-Converting Enzyme and Aldosterone Serum Levels as Prognostic and Predictive Biomarkers for Cediranib in NCIC Clinical Trials Group Study BR.24. : Clinical lung cancer.

Chicago

Bar Jair, Ding Keyue, Zhao Huijun, Han Lei, Laurie Scott A, Seymour Lesley, Addison Christina L, Shepherd Frances A, Goss Glenwood D, Dimitroulakos Jim and Bradbury Penelope A. 20160815. Angiotensin-Converting Enzyme and Aldosterone Serum Levels as Prognostic and Predictive Biomarkers for Cediranib in NCIC Clinical Trials Group Study BR.24. : Clinical lung cancer.

Harvard

Bar J., Ding K., Zhao H., Han L., Laurie S. A., Seymour L., Addison C. L., Shepherd F. A., Goss G. D., Dimitroulakos J. and Bradbury P. A. (20160815). Angiotensin-Converting Enzyme and Aldosterone Serum Levels as Prognostic and Predictive Biomarkers for Cediranib in NCIC Clinical Trials Group Study BR.24. : Clinical lung cancer.

MLA

Bar Jair, Ding Keyue, Zhao Huijun, Han Lei, Laurie Scott A, Seymour Lesley, Addison Christina L, Shepherd Frances A, Goss Glenwood D, Dimitroulakos Jim and Bradbury Penelope A. Angiotensin-Converting Enzyme and Aldosterone Serum Levels as Prognostic and Predictive Biomarkers for Cediranib in NCIC Clinical Trials Group Study BR.24. : Clinical lung cancer. 20160815.